responses to a consist of of drugs.

The new test is CE marked in Europe for in vitro diagnostic use and available for research use in other countries.

Please inspect www.qiagen.com for a more comprehensive press release.

About Olerup SSP AB Olerup SSP AB is world leading in the development of reagents and kits for genomic HLA typing, which is a required step performed prior to a transplantation proceeding in symmetry to join the donor and recipient. HLA typing is primarily carried out in the presence of bone marrow transplantations (hematopoietic withstand cell transplantation) however is also carried out in conjunction with solid organ transplantations (kidneys, lungs, hearts, etc). The less ill the match between donor and recipient, the lower the risk of transplantation-related complications. Genomic HLA typing is therefore a standard transaction prior to bone marrow transplantations. Olerup SSP AB was acquired by LinkMed AB in July 2008.

Also visit www.linkmed.se

This information was brought to you by Cision http://newsroom.cision.com

LinkMed (STO:LMED), in collaboration with innovators, develops life science companies. By contributing entrepreneurship and capital, LinkMed has created a portfolio of twelve companies, seven in biotechnology and five in medical technology. The company